Autophagy & Mitophagy (Spermidine, Urolithin A)

Navigation & Context

• Parent Hub: 04 - Longevity & Environment MOC
• Literature Dossier: Autophagy & Mitophagy (Spermidine, Urolithin A) - References
• Related Nodes: Mitochondrial Biogenesis & Uncoupling, NAD+ Salvage Pathway (NMN, NR, CD38 Inhibition), Cellular Senescence & Senolytics (Fisetin, Quercetin, Dasatinib)

---

1. Geroscience & Biophysical Mechanism

Disabled macroautophagy and mitophagy represent primary hallmarks of aging, leading to the accumulation of misfolded protein aggregates (lipofuscin, $\alpha$-synuclein, amyloid-$\beta$) and ROS-leaking, depolarized mitochondria.

1.1 Macroautophagy Induction via Spermidine & Trehalose

• EP300 Acetyltransferase Inhibition: The endogenous polyamine Spermidine acts as a caloric restriction mimetic by competitively inhibiting the lysine acetyltransferase $\text{EP300}$ ($p300$). Deacetylation of cytosolic autophagy-related proteins ($\text{ATG5, ATG7, ATG12, LC3}$) and activation of $\text{ULK1}$ / $\text{AMPK}$ initiates autophagosome formation without requiring $\text{SIRT1}$ or $\text{mTORC1}$ starvation signals alone.
• eIF5A Hypusination & TFEB Translation: Spermidine is the sole substrate for deoxyhypusine synthase ($\text{DHPS}$), which hypusinates eukaryotic translation initiation factor 5A ($\text{eIF5A}$). Hypusinated $\text{eIF5A}$ resolves ribosomal stalling at polyproline motifs required to translate $\text{TFEB}$ (the master transcription factor for lysosomal biogenesis) and $\text{ATG3}$ (which lipidates $\text{LC3-I}$ to $\text{LC3-II}$).
• Trehalose ($\text{SLC2A8/GLUT8}$ Blockade): A natural $\alpha$-linked disaccharide that transiently blocks hepatocyte and neuronal $\text{GLUT8}$ glucose transport, activating $\text{AMPK/ULK1}$ and nuclear translocation of $\text{TFEB}$ independently of $\text{mTOR}$.

1.2 Selective Mitophagy via Urolithin A

• The Ellagitannin Microbiome Bottleneck: Dietary ellagitannins (pomegranates, walnuts, berries) require specific gut Gordonibacter / Ellagibacter species to convert ellagic acid into Urolithin A (UA). Only ~30–40% of humans are natural “UA producers” capable of synthesizing therapeutic levels from diet alone; direct UA supplementation bypasses this microbiome variability, delivering 6-fold higher plasma exposure than pomegranate juice.
• PINK1/Parkin & BNIP3 Pathway: When mitochondrial membrane potential ($\Delta {\Psi }_m$) drops in damaged mitochondria, $\text{PINK1}$ kinase stabilizes on the outer mitochondrial membrane and phosphorylates ubiquitin and the E3 ubiquitin ligase $\text{Parkin}$ ($\text{PRKN}$). Urolithin A amplifies $\text{PINK1/Parkin}$ recruitment and receptor-mediated mitophagy ($\text{BNIP3/NIX}$), tagging defective mitochondria with phospho-ubiquitin chains for engulfment by ${\text{LC3-II}}^{+}$ mitophagosomes and subsequent replacement via PGC-1α mitochondrial biogenesis.

---

2. Actionable Protocol & Dosing Architecture

Compound	Daily Dosage	Timing & Bioavailability	Primary Target
Urolithin A (Pure Micronized)	$500\text{–}1,000\text{ mg/day}$	AM (with or without food; $t_{\max }\approx 6\text{ h}$)	Skeletal muscle, cardiac, and hematopoietic stem cell mitophagy ($\text{PINK1/Parkin}$)
Spermidine (Wheat Germ Extract or Trihydrochloride + Dietary Natto/Mushrooms/Aged Cheese)	$6\text{–}15\text{ mg/day}$ supplemental (targeting total dietary + supplemental intake $>15\text{–}20\text{ mg/day}$)	With meals or during morning fasting window	Systemic macroautophagy ($\text{EP300}$ inhibition, $\text{eIF5A-TFEB}$ translation), memory, hair/epithelial stem cells
Trehalose	$5\text{–}15\text{ g/day}$ (replacing sucrose in coffee/tea)	Morning / Pre-workout	$\text{TFEB}$-mediated lysosomal clearance and vascular endothelial autophagy
Fasting + Zone 2 Synergy	$16\text{–}18\text{ h}$ time-restricted feeding + $60\text{ min}$ fasted Zone 2	$2\text{–}3\times \text{/week}$	Elevates $\text{AMP:ATP}$ ratio $\to \text{AMPK}\alpha \to \text{ULK1 (Ser317/777)}$ phosphorylation

---

3. Biomarkers & Quantification

• Plasma Acylcarnitines: Reduction in plasma short- and medium-chain acylcarnitines ($\text{C2, C6, C8, C10, C14:1}$) reflects improved mitochondrial fatty acid $\beta$-oxidation efficiency following Urolithin A supplementation.
• Inflammatory & Mitophagy Surrogates: $\text{hs-CRP}$ (reduced by ~20–30% in UA trials), plasma $\text{GDF-15}$ (marker of mitochondrial integrated stress response), and ${\text{VO}}_2\text{ max}$ / ventilatory threshold.
• Autophagic Flux (Research Assays): PBMC $\text{LC3-II/LC3-I}$ ratio, $\text{p62/SQSTM1}$ clearance, and B-cell/T-cell hypusinated $\text{eIF5A}$ levels.

---

4. Key Scientific Evidence Summary

Full clinical trial citations and metrics are cataloged in Autophagy & Mitophagy (Spermidine, Urolithin A) - References:

• Andreux et al. (2019, Nature Metabolism): First-in-human RCT showing $500\text{–}1,000\text{ mg/day}$ Urolithin A for 4 weeks lowered plasma acylcarnitines and upregulated skeletal muscle mitochondrial respiratory and mitophagy gene sets ($\text{GABARAPL1, PINK1, Parkin}$) in sedentary older adults.
• Liu et al. (2022, JAMA Network Open): 4-month RCT ($n=66$ older adults, $1,000\text{ mg/day}$ UA) significantly increased skeletal muscle endurance (+95 vs. +11 contractions in hand/leg fatigue tests, $p=0.02$) and lowered plasma acylcarnitines and $\text{CRP}$.
• Singh et al. (2022, Cell Reports Medicine): 4-month RCT ($n=88$ middle-aged adults) showed $500\text{–}1,000\text{ mg/day}$ UA increased hamstring leg strength by 12% ($p=0.027$), improved aerobic endurance (${\text{VO}}_2\text{ peak}$), and boosted muscle phosphorylated Parkin (Ser65) protein expression.
• Kiechl et al. (2018, American Journal of Clinical Nutrition): Prospective 20-year Bruneck cohort ($n=829$) demonstrated that the highest tertile of dietary spermidine intake was associated with a 5.7-year survival advantage and a 40% lower risk of all-cause mortality (HR $0.60$, $p<0.001$).